| Autor: |
Lojanapiwat B; Department of Surgery, Faculty of Medicine, Chiang Mai University, Thailand., Lee JY; Department of Urology, St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea., Gang Z; Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China., Kim CS; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Fai NC; SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Robotic Surgical System Training Programme, Jockey Club Minimally Invasive Surgical Skills Center, The Chinese University of Hong Kong, Hong Kong, China.; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China., Hakim L; Department of Urology, Airlangga University/Dr. Soetomo General Hospital of Surabaya, Surabaya, East Java, Indonesia., Umbas R; Department of Urology, Dr. Cipto Mangunkusumo Hospital/Faculty of Medicine, University of Indonesia, Depok City, West Java, Indonesia., Ong TA; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Lim J; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Letran JL; Department of Urology, Cardinal Santos Medical Center, Manila, Philippines., Chiong E; Department of Urology, University Surgical Cluster, National University Health System (NUHS), Singapore., Lee SH; Department of Urology, Severance Hospital, Yonsei University School of Medicine, Seoul, Korea., Türkeri L; Department of Urology, Acıbadem University School of Medicine, Istanbul, Turkey., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Moretti K; School of Population Health, University of South Australia, Discipline of Surgery,University of Adelaide, SA, Australia., Cooperberg M; Department of Urology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.; Department of Epidemiology & Biostatistics, School of Medicine, University of California San Francisco, San Francisco, CA, USA., Carlile R; Department of Surgery, University of Hawaii, HI, USA., Hinotsu S; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan., Hirao Y; Osaka Gyoumeikan Hospital, Osaka, Japan., Kitamura T; Asoka Hospital, Jisei-kai Shinsui Clinic, Tokyo, Japan., Horie S; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Onozawa M; International University of Health and Welfare School of Medicine, Chiba, Japan., Kitagawa Y; Komatsu Municipal Hospital, Komatsu, Japan., Namiki M; Hasegawa Hospital, Toyama, Japan., Fukagai T; Department of Urology, Showa University Koto Toyosu Hospital, Tokyo, Japan., Miyazaki J; International University of Health and Welfare School of Medicine, Chiba, Japan., Akaza H; Department of Strategic Investigation on Comprehensive Cancer Network, Graduate School of Interdisciplinary Information Studies, University of Tokyo, Tokyo, Japan.; Emeritus Professor, University of Tsukuba, Tsukuba, Japan. |
| Abstrakt: |
The Asian Prostate Cancer (A-CaP) study is an Asia-wide initiative that was launched in December 2015 in Tokyo, Japan, with the objective of surveying information about patients who have received a histopathological diagnosis of prostate cancer (PCa) and are undergoing treatment and clarifying distribution of staging, the actual status of treatment choices, and treatment outcomes. The study aims to clarify the clinical situation for PCa in Asia and use the outcomes for the purposes of international comparison. Following the first meeting in Tokyo in December 2015, the second A-CaP meeting was held in Seoul, Korea, in September 2016. This, the third A-CaP meeting, was held on October 14, 2017, in Chiang Mai, Thailand, with the participation of members and collaborators from 12 countries and regions. In the meeting, participating countries and regions presented the current status of data collection, and the A-CaP office presented a preliminary analysis of the registered cases received from each country and region. Participants discussed ongoing challenges relating to data input and collection, institutional, and legislative issues that may present barriers to data sharing, and the outlook for further patient registrations through to the end of the registration period in December 2018. In addition to A-CaP-specific discussions, a series of special lectures were also delivered on the situation for health insurance in the United States, the correlation between insurance coverage and PCa outcomes, and the outlook for robotic surgery in the Asia-Pacific region. Members also confirmed the principles of authorship in collaborative studies, with a view to publishing original articles based on A-CaP data in the future. |
